7-氯-2-喹喔啉酮
|
C337574-250mg
|
≥95% |
59489-30-4 |
250mg
|
¥ 2999.9
|
期货,请咨询 |
阿拉丁 |
7-氯-2-羟基喹啉-3-甲醛
|
C337509-5g
|
|
73568-43-1 |
5g
|
¥ 5631.9
|
期货,请咨询 |
阿拉丁 |
7-氯-2-羟基喹啉-3-甲醛
|
C337509-1g
|
|
73568-43-1 |
1g
|
¥ 1367.9
|
期货,请咨询 |
阿拉丁 |
6-氯-2-硝基吡啶-3-醇
|
C337255-5g
|
≥97% |
887471-39-8 |
5g
|
¥ 1789.9
|
现货 |
阿拉丁 |
6-氯-2-硝基吡啶-3-醇
|
C337255-1g
|
≥97% |
887471-39-8 |
1g
|
¥ 444.9
|
现货 |
阿拉丁 |
2-氯-3-苯基喹啉
|
C336947-100mg
|
≥95% |
2859-30-5 |
100mg
|
¥ 368.9
|
现货 |
阿拉丁 |
盐酸CDKi
|
C336624-50mg
|
≥98% |
70035-83-5 |
50mg
|
¥ 8809.9
|
现货 |
阿拉丁 |
盐酸CDKi
|
C336624-25mg
|
≥98% |
70035-83-5 |
25mg
|
¥ 5505.9
|
现货 |
阿拉丁 |
CDC25磷酸酶抑制剂I,BN82002
|
C336618-50mg
|
≥97% |
396073-89-5 |
50mg
|
¥ 3934.9
|
期货,请咨询 |
阿拉丁 |
CDC25磷酸酶抑制剂I,BN82002
|
C336618-25mg
|
≥97% |
396073-89-5 |
25mg
|
¥ 2193.9
|
期货,请咨询 |
阿拉丁 |
CDC25磷酸酶抑制剂I,BN82002
|
C336618-250mg
|
≥97% |
396073-89-5 |
250mg
|
¥ 13163.9
|
期货,请咨询 |
阿拉丁 |
CDC25磷酸酶抑制剂I,BN82002
|
C336618-10mg
|
≥97% |
396073-89-5 |
10mg
|
¥ 1271.9
|
期货,请咨询 |
阿拉丁 |
CDC25磷酸酶抑制剂I,BN82002
|
C336618-100mg
|
≥97% |
396073-89-5 |
100mg
|
¥ 6581.9
|
期货,请咨询 |
阿拉丁 |
5-氯-2,4-二甲氧基嘧啶
|
C336573-250mg
|
≥97% |
123551-49-5 |
250mg
|
¥ 105.9
|
现货 |
阿拉丁 |
2-氯-6-硝基喹啉
|
C336140-5g
|
≥97% |
29969-57-1 |
5g
|
¥ 8730.9
|
现货 |
阿拉丁 |
细胞色素P450 14a-脱甲基酶抑制剂1A
|
C336096-50mg
|
≥98% |
1155360-99-8 |
50mg
|
¥ 6090.9
|
现货 |
阿拉丁 |
细胞色素P450 14a-脱甲基酶抑制剂1A
|
C336096-25mg
|
≥98% |
1155360-99-8 |
25mg
|
¥ 3382.9
|
现货 |
阿拉丁 |
细胞色素P450 14a-脱甲基酶抑制剂1A
|
C336096-100mg
|
≥98% |
1155360-99-8 |
100mg
|
¥ 10965.9
|
现货 |
阿拉丁 |
7-氯-4-肼基喹啉盐酸盐
|
C336022-5g
|
≥97% |
786727-08-0 |
5g
|
¥ 6487.9
|
现货 |
阿拉丁 |
7-氯-4-肼基喹啉盐酸盐
|
C336022-250mg
|
≥97% |
786727-08-0 |
250mg
|
¥ 538.9
|
现货 |
阿拉丁 |
7-氯喹啉-3-羧酸
|
C335983-50mg
|
≥98% |
892874-49-6 |
50mg
|
¥ 369.9
|
现货 |
阿拉丁 |
7-氯喹啉-3-羧酸
|
C335983-250mg
|
≥98% |
892874-49-6 |
250mg
|
¥ 888.9
|
现货 |
阿拉丁 |
7-(氯甲基)-2-甲基-5H-[1,3]噻唑并[3,2-a]嘧啶-5-酮
|
C335973-5g
|
≥95% |
943656-55-1 |
5g
|
¥ 2677.9
|
现货 |
阿拉丁 |
7-(氯甲基)-2-甲基-5H-[1,3]噻唑并[3,2-a]嘧啶-5-酮
|
C335973-250mg
|
≥95% |
943656-55-1 |
250mg
|
¥ 189.9
|
现货 |
阿拉丁 |